BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31613602)

  • 21. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hollow/porous nanostructures derived from nanoscale metal-organic frameworks towards high performance anodes for lithium-ion batteries.
    Hu L; Chen Q
    Nanoscale; 2014; 6(3):1236-57. PubMed ID: 24356788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET/CT, MR, and PET/MR in Lymphoma and Melanoma.
    Schwenzer NF; Pfannenberg AC
    Semin Nucl Med; 2015 Jul; 45(4):322-31. PubMed ID: 26050659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hollow structural metal-organic frameworks exhibit high drug loading capacity, targeted delivery and magnetic resonance/optical multimodal imaging.
    Gao X; Cui R; Song L; Liu Z
    Dalton Trans; 2019 Nov; 48(46):17291-17297. PubMed ID: 31714562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
    Chavdarova LI; Tzonevska AD; Piperkova EN
    Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hot Topics of Research in Musculoskeletal Imaging: PET/MR Imaging, MR Fingerprinting, Dual-energy CT Scan, Ultrashort Echo Time.
    Kooraki S; Assadi M; Gholamrezanezhad A
    PET Clin; 2019 Jan; 14(1):175-182. PubMed ID: 30420218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Cerenkov imaging using 18F-FDG.
    Spinelli AE; Boschi F
    J Nucl Med; 2014 Mar; 55(3):523. PubMed ID: 24449596
    [No Abstract]   [Full Text] [Related]  

  • 30. Reply: Human Cerenkov imaging using 18F-FDG.
    Thorek DL; Riedl CC; Grimm J
    J Nucl Med; 2014 Mar; 55(3):523-4. PubMed ID: 24449595
    [No Abstract]   [Full Text] [Related]  

  • 31. From PET/CT to PET/MRI: advances in instrumentation and clinical applications.
    Hu Z; Yang W; Liu H; Wang K; Bao C; Song T; Wang J; Tian J
    Mol Pharm; 2014 Nov; 11(11):3798-809. PubMed ID: 25058336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodynamic Therapy Based on Nanoscale Metal-Organic Frameworks: From Material Design to Cancer Nanotherapeutics.
    Guan Q; Li YA; Li WY; Dong YB
    Chem Asian J; 2018 Nov; 13(21):3122-3149. PubMed ID: 30183134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole-body MR or PET-CT?
    Schmidt GP
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S142-3. PubMed ID: 23083566
    [No Abstract]   [Full Text] [Related]  

  • 34. High-Z Metal-Organic Frameworks for X-ray Radiation-Based Cancer Theranostics.
    Neufeld MJ; Lutzke A; Pratx G; Sun C
    Chemistry; 2021 Feb; 27(10):3229-3237. PubMed ID: 32902003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Redox-Sensitive Nanoscale Coordination Polymers for Drug Delivery and Cancer Theranostics.
    Zhao J; Yang Y; Han X; Liang C; Liu J; Song X; Ge Z; Liu Z
    ACS Appl Mater Interfaces; 2017 Jul; 9(28):23555-23563. PubMed ID: 28636308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET/MRI: Emerging Clinical Applications in Oncology.
    Fraum TJ; Fowler KJ; McConathy J
    Acad Radiol; 2016 Feb; 23(2):220-36. PubMed ID: 26521689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-directed metal-organic framework nanoparticles for targeted drug delivery.
    Cherkasov VR; Mochalova EN; Babenyshev AV; Rozenberg JM; Sokolov IL; Nikitin MP
    Acta Biomater; 2020 Feb; 103():223-236. PubMed ID: 31843718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-pot synthesis of pH-responsive charge-switchable PEGylated nanoscale coordination polymers for improved cancer therapy.
    Yang Y; Xu L; Zhu W; Feng L; Liu J; Chen Q; Dong Z; Zhao J; Liu Z; Chen M
    Biomaterials; 2018 Feb; 156():121-133. PubMed ID: 29195181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Advances in Imaging of Small and Large Bowel.
    Das CJ; Manchanda S; Panda A; Sharma A; Gupta AK
    PET Clin; 2016 Jan; 11(1):21-37. PubMed ID: 26590441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imparting Designer Biorecognition Functionality to Metal-Organic Frameworks by a DNA-Mediated Surface Engineering Strategy.
    Ning W; Di Z; Yu Y; Zeng P; Di C; Chen D; Kong X; Nie G; Zhao Y; Li L
    Small; 2018 Mar; 14(11):e1703812. PubMed ID: 29450964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.